Search results for "Cerebral Cortex"

showing 10 items of 529 documents

Transient expression of synaptogyrin in the ganglionic eminence of the human fetal brain

2000

Summary The ganglionic eminence (GE) representing a conspicuous bulb-like elevation of the telencephalic proliferative zone has recently been shown to be involved in the establishment of cortical connections. This study demonstrates the presence of synaptogyrin-immunoreactivity in a large number of cell bodies of the human GE between 12 and 20 weeks of gestation. From the 20 th week onwards synaptogyrin expression sharply declines. No immunoreactive structures are detectable in the 23 rd week or later. As the GE persists nearly throughout the entire fetal period these results show that its neurochemical features change distinctly in the course of development. The synaptogyrin-immunoreactive…

medicine.medical_specialtyInternal capsuleGanglionic eminenceGestational AgeNerve Tissue ProteinsBiologyEmbryonic and Fetal DevelopmentNeurochemicalPregnancyInternal medicinemedicineHumansCerebral CortexSynaptogyrinsFetal periodBrainMembrane ProteinsAbortion InducedGeneral MedicineAbortion SpontaneousEndocrinologyCell bodiesHuman fetalImmunohistochemistryFemaleAnatomySynaptogyrinDevelopmental BiologyAnnals of Anatomy - Anatomischer Anzeiger
researchProduct

Fresh cell therapy followed by fatal coma

1986

A 60-year-old woman received a 3-day course of nine injections of “fresh” cells from fetal lamb ovary, placenta, brain (hypothalamus) and liver. There were no immediate complications, but a few days later she developed headache, fever and hemiparesis. She subsequently fell into a coma and died 3 weeks after her fresh cell therapy and 2 weeks after the onset of her clinical symptoms. Autopsy revealed perivenous leucoencephalopathy with a probably steroid-treatment-induced paucity of perivascular inflammation. Fresh cell therapy, clinical symptomatology and morphological findings suggest, though do not prove, that this patient's monophasic and probably immune-mediated disease is a rare and fa…

medicine.medical_specialtyNeurologyCell- and Tissue-Based TherapyImmunoglobulinsOvaryAutopsyImmunoenzyme TechniquesCell therapyPonsPlacentamedicineHumansComaMyelin SheathCerebral CortexComabusiness.industryMacrophagesEncephalomyelitis Acute DisseminatedMiddle AgedSurgeryMicroscopy Electronmedicine.anatomical_structureHemiparesisNeurologyBlood-Brain BarrierAnesthesiaFemaleNeurology (clinical)medicine.symptomComplicationbusinessJournal of Neurology
researchProduct

Study and modulation of human cortical excitability with transcranial magnetic stimulation.

1998

Transcranial magnetic stimulation (TMS) can be applied in different paradigms to obtain a measure of various aspects of cortical excitability. These different TMS paradigms provide information about different neurotransmitter systems, enhance our understanding about the pathophysiology of neuropsychiatric conditions, and in the future may be helpful as a guide for pharmacological interventions. In addition, repetitive TMS (rTMS) modulates cortical excitability beyond the duration of the rTMS trains themselves. Depending on rTMS parameters, a lasting inhibition or facilitation of cortical excitability can be induced. These effects can be demonstrated neurophysiologically or by combining rTMS…

medicine.medical_specialtyNeurologyPhysiologyNerve netmedicine.medical_treatmentNeural ConductionNeural Inhibitionbehavioral disciplines and activitiesSynaptic TransmissionElectromagnetic FieldsNeuroimagingPhysiology (medical)Physical Stimulationmental disordersNeural PathwaysmedicineHumansEvoked PotentialsNeurorehabilitationCerebral CortexDepressive DisorderMovement Disordersbusiness.industrymusculoskeletal neural and ocular physiologyNeural InhibitionTranscranial magnetic stimulationmedicine.anatomical_structurenervous systemNeurologyCerebral cortexNeurology (clinical)Nerve NetbusinessNeurosciencepsychological phenomena and processesPhysical StimulationJournal of clinical neurophysiology : official publication of the American Electroencephalographic Society
researchProduct

Regulation of NT Receptors after Chronic Treatment with Typical and Atypical Neuroleptic Drugs

1991

Neurotensin is a tridecapeptide, which produces central effects such as hypotension, hypothermia, muscle relaxation, analgesia, antinociception, and reduces locomotor activity (Nemeroff et al., 1977). In the recent years, several lines of evidences indicated the great importance of the dopamine (DA)- neurotensin (NT) interaction taking place mostly in the mesolimbocortical areas, both at cell bodies (A10 DA-ergic group located in the ventral tegmental area -VTA-) and nerve terminal level (cerebral cortex, n. accumbens, olfactory tubercle, ventral n. caudato-putamen) (Quirion, 1983; Nemeroff, et al., 1984; Nemeroff, 1986). Immunocytochemical data indicated the presence of NT-like immunoreact…

medicine.medical_specialtyOlfactory tubercleBiologyVentral tegmental areaMidbrainchemistry.chemical_compoundEndocrinologymedicine.anatomical_structurenervous systemchemistryCerebral cortexDopamineInternal medicineBasal gangliamedicineNeurotensin receptorNeurotensinmedicine.drug
researchProduct

Effects of severe arterial hypocapnia on regional blood flow regulation, tissuePO2 and metabolism in the brain cortex of cats

1981

The effect of a stepwise decrease in PaCO2 from 3.9-1.6 kPa on rCBF, rCMRO2, tissue PO2 and concentrations of glucose, lactate, pyruvate, ATP, ADP, AMP and phosphocreatine in the brain cortex was studied in cats lightly anaesthetized with sodium pentobarbital. 1. Moderate lowering of PaCO2 to 2.5 kPa induced in all animals a homogeneous decrease of rCBF in corresponding areas of the right and left hemisphere. Mean rCBF fell from 129.2 to 103.1 ml X 100 g-1 X min-1, while rCMRO2 remained unchanged (12.7-12.9 ml X 100 g-1 X min-1). The tissue PO2 frequency histograms showed a shift to lower values without indicating the presence of brain tissue hypoxia. 2. Severe arterial hypocapnia (PaCO2 = …

medicine.medical_specialtyPhosphocreatinePhysiologyClinical BiochemistryPhosphocreatinechemistry.chemical_compoundOxygen ConsumptionHypocapniaAdenine nucleotidePhysiology (medical)Internal medicinePyruvic AcidHyperventilationmedicineAnimalsHyperventilationLactic AcidPyruvatesCerebral CortexAdenine NucleotidesCarbon DioxideHypoxia (medical)medicine.diseaseOxygenGlucoseEndocrinologymedicine.anatomical_structurechemistryCerebral cortexCerebrovascular CirculationAnesthesiaCatsLactatesVascular resistanceVascular ResistancePyruvic acidmedicine.symptomcirculatory and respiratory physiologyPflügers Archiv - European Journal of Physiology
researchProduct

cGMP MODULATES STEM CELLS DIFFERENTIATION TO NEURONS IN BRAIN IN VIVO

2010

During brain development neural stem cells may differentiate to neurons or to other cell types. The aim of this work was to assess the role of cGMP (cyclic GMP) in the modulation of differentiation of neural stem cells to neurons or non-neuronal cells. cGMP in brain of fetuses was reduced to 46% of controls by treating pregnant rats with nitroarginine-methylester (L-NAME) and was restored by co-treatment with sildenafil.Reducing cGMP during brain development leads to reduced differentiation of stem cells to neurons and increased differentiation to non-neuronal cells. The number of neurons in the prefrontal cortex originated from stem cells proliferating on gestational day 14 was 715 +/- 14/…

medicine.medical_specialtyPhosphodiesterase InhibitorsNeurogenesissildenafilHippocampusPrefrontal CortexApoptosisHippocampusPiperazinesSildenafil Citratenitric oxideNeurosphereInternal medicinemedicineAnimalsratSulfonesEnzyme InhibitorsRats WistarCyclic GMPNitritesCerebral CortexNeuronsNitratesbiologyGeneral NeuroscienceStem CellsBrainCell DifferentiationNeural stem cellRatsNeuroepithelial cellmedicine.anatomical_structureEndocrinologyNG-Nitroarginine Methyl Esternervous systemPurinesbiology.proteinNeuronStem cellNeuNAdult stem cell
researchProduct

Thyroid hormones induce sumoylation of the cold shock domain-containing protein PIPPin in developing rat brain and in cultured neurons.

2006

We previously identified a cold shock domain (CSD)-containing protein (PIPPin), expressed at high level in brain cells. PIPPin has the potential to undergo different post-translational modifications and might be a good candidate to regulate the synthesis of specific proteins in response to extracellular stimuli. Here we report the effects of thyroid hormone (T3) on PIPPin expression in developing rat brain. We found that a significant difference among euthyroid- and hypothyroid- newborn rats concerns sumoylation of nuclear PIPPin, that is abolished by hypothyroidism. Moreover, T3-dependence of PIPPin sumoylation has been confirmed in cortical neurons purified from brain cortices and culture…

medicine.medical_specialtySUMO-1 ProteinSUMO proteinDeveloping rat brainNerve Tissue ProteinsEndocrinologyAntithyroid AgentsHypothyroidismPregnancyInternal medicinemedicineExtracellularAnimalsRats WistarCells CulturedCell NucleusCerebral CortexNeuronsbiologyRNA-Binding ProteinsCold-shock domainChromatinProtein Structure TertiaryRatsThyroid hormoneChemically defined mediumCell nucleusmedicine.anatomical_structureHistoneEndocrinologyAnimals NewbornPropylthiouracilPrenatal Exposure Delayed Effectsbiology.proteinTriiodothyronineRNA-binding proteins (RBPs)FemaleRabbitsNucleusEndocrinology
researchProduct

Vestibular compensation of otolith graviceptive dysfunction in stroke patients

2022

BACKGROUND AND PURPOSE A sensitive and frequent clinical sign of a vestibular tone imbalance is the tilt of the perceived subjective visual vertical (SVV). There are no data yet focusing on lesion location at the cortical level as a factor for predicting compensation from the tilt of the SVV. METHODS With modern voxelwise lesion behavior mapping analysis, the present study determines whether lesion location in 23 right-hemispheric cortical stroke patients with an otolith dysfunction could predict the compensation of a vestibular tone imbalance in the chronic stage. RESULTS Our statistical anatomical lesion analysis revealed that lesions of the posterior insular cortex are involved in vestib…

medicine.medical_specialtyStroke patientpathology [Otolithic Membrane]610 MedizinInsular cortexcompensationLesionOtolithic MembranePhysical medicine and rehabilitation610 Medical sciencesdiagnostic imaging [Stroke]HumansMedicinecomplications [Stroke]ddc:610StrokeOtolithCerebral CortexVestibular systemChronic stagebusiness.industryCompensation (psychology)subjective visual verticalmedicine.diseasestrokeStrokemedicine.anatomical_structureNeurologyinsular cortexpathology [Stroke]pathology [Cerebral Cortex]sense organsNeurology (clinical)medicine.symptombusinessEuropean Journal of Neurology
researchProduct

Regional cerebral blood flow (rCBF) changes following local brain compression in the cat.

1968

medicine.medical_specialtyTime FactorsClinical BiochemistryBlood PressureInternal medicineBrain compressionmedicinePressureAnimalsHomeostasisAnesthesiaBrain ConcussionCerebral CortexCATSbusiness.industryGeneral MedicineRespiration ArtificialCerebrovascular CirculationBlood pressuremedicine.anatomical_structureCerebral blood flowCerebral cortexIschemic Attack TransientRegional Blood FlowCerebrovascular CirculationCardiologyCatsbusinessHomeostasisScandinavian journal of clinical and laboratory investigation. Supplementum
researchProduct

The nicotinic acetylcholine receptor agonist (±)-epibatidine increases FGF-2 mRNA and protein levels in the rat brain

2000

Abstract In a previous work, we showed that acute intermittent nicotine treatment up-regulates the level of fibroblast growth factor-2 (FGF-2) mRNA in brain regions of tel- and mesencephalon of rats suggesting that neuroprotective effect of (−)nicotine may, at least in part, involve an activation of the neuronal FGF-2 signalling. The present experiments were designed to extend the study on the nicotinic receptor mediated up-regulation of FGF-2 mRNA levels to the use of the potent nicotinic acetylcholine receptor (nAChR) agonist (±)-epibatidine. The (±)-epibatidine treatment led to a strong and long lasting up-regulation of FGF-2 mRNA expression in the cerebral cortex, in the hippocampal for…

medicine.medical_specialtyTime FactorsNicotinic acetylcoline receptor agonistPyridinesBlotting WesternNerve Tissue ProteinsNicotinic AntagonistsFibroblast growth factor-2MecamylamineBiologyHippocampusRats Sprague-DawleyNicotineCellular and Molecular NeuroscienceInternal medicineMecamylaminemedicineGlial cell line-derived neurotrophic factorAnimalsGlial Cell Line-Derived Neurotrophic FactorNerve Growth FactorsNicotinic AgonistsRNA MessengerMolecular BiologyIn Situ HybridizationEpibatidineCerebral CortexBrain-derived neurotrophic factorDose-Response Relationship DrugBrain-Derived Neurotrophic FactorBrainBridged Bicyclo Compounds HeterocyclicCorpus StriatumRatsSpecific Pathogen-Free OrganismsNicotinic acetylcholine receptorEndocrinologyNicotinic agonistGene Expression RegulationEpibatidinebiology.proteinFibroblast Growth Factor 2Alpha-4 beta-2 nicotinic receptorFibroblast growth factor receptor-1medicine.drugMolecular Brain Research
researchProduct